however, several mechanisms have been proposed
10.1186/s13098-022-00924-8 Summary Keywords GLP-1 receptor agonists, DPP-4 inhibitors, FAERS, adverse events, biliary disorders, pharmacovigilance Citation He L, Li J, Cheng X, Luo L and Huang Y (2025) Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis
Realistic expectations include: Weight loss: 0.5-1 kg/week Improved health markers (blood pressure, cholesterol, blood sugar) Increased energy and mental clarity Reduced inflammation and oxidative stress For optimal results, consider: Starting slowly and adjusting your fasting schedule Eating nutrient-dense foods during your eating window Staying hydrated and managing hunger pangs Monitoring progress and adjusting your approach Consulting a healthcare professional before beginning Dr
IGFBP7 induces differentiation and loss of survival of human acute myeloid leukemia stem cells without affecting normal hematopoiesis